Cargando…

MicroRNA-101 Regulates 6-Hydroxydopamine-Induced Cell Death by Targeting Suppressor/Enhancer Lin-12-Like in SH-SY5Y Cells

Endoplasmic reticulum (ER) stress has been reported as a cause of Parkinson’s disease (PD). We have previously reported that the ubiquitin ligase HMG-CoA reductase degradation 1 (HRD1) and its stabilizing factor suppressor/enhancer lin-12-like (SEL1L) participate in the ER stress. In addition, we re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omura, Tomohiro, Nomura, Luna, Watanabe, Ran, Nishiguchi, Hiroki, Yamamoto, Kazuhiro, Imai, Satoshi, Nakagawa, Shunsaku, Itohara, Kotaro, Yonezawa, Atsushi, Nakagawa, Takayuki, Kunimasa, Junichi, Yano, Ikuko, Matsubara, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695805/ https://www.ncbi.nlm.nih.gov/pubmed/34955743 http://dx.doi.org/10.3389/fnmol.2021.748026

Ejemplares similares

Gefitinib and Erlotinib Lead to Phosphorylation of Eukaryotic Initiation Factor 2 Alpha Independent of Epidermal Growth Factor Receptor in A549 Cells
por: Koyama, Satoshi, et al.
Publicado: (2015)

A Minimal Physiologically‐Based Pharmacokinetic Model for Tacrolimus in Living‐Donor Liver Transplantation: Perspectives Related to Liver Regeneration and the cytochrome P450 3A5 (CYP3A5) Genotype
por: Itohara, Kotaro, et al.
Publicado: (2019)

Time-Dependent Structural Alteration of Rituximab Analyzed by LC/TOF-MS after a Systemic Administration to Rats
por: Otani, Yuki, et al.
Publicado: (2017)

Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case–control study
por: Ikuta, Keiko, et al.
Publicado: (2021)

Effect of riboflavin deficiency on development of the cerebral cortex in Slc52a3 knockout mice
por: Jin, Congyun, et al.
Publicado: (2020)

Population pharmacokinetics of everolimus in adult liver transplant patients: Comparison to tacrolimus disposition and extrapolation to pediatrics
por: Itohara, Kotaro, et al.
Publicado: (2022)

Disruption of Slc52a3 gene causes neonatal lethality with riboflavin deficiency in mice
por: Yoshimatsu, Hiroki, et al.
Publicado: (2016)

Ghrelin alleviates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells
por: He, Xin, et al.
Publicado: (2021)

Lipid Analysis of the 6-Hydroxydopamine-Treated SH-SY5Y Cell Model for Parkinson’s Disease
por: Xicoy, Helena, et al.
Publicado: (2019)

Protective effect of theaflavins on neuron against 6-hydroxydopamine-induced apoptosis in SH-SY5Y cells
por: Luo, Zihua, et al.
Publicado: (2012)

Protective effect of Artemisia absinthium on 6-hydroxydopamine-induced toxicity in SH-SY5Y cell line
por: Rashidi, Roghayeh, et al.
Publicado: (2021)

Prevalence of and risk factors for adverse events in Alzheimer’s patients receiving anti-dementia drugs in at-home care
por: Imai, Hirohisa, et al.
Publicado: (2020)

Sinapic Acid Protects SH-SY5Y Human Neuroblastoma Cells against 6-Hydroxydopamine-Induced Neurotoxicity
por: Tungalag, Tsendsuren, et al.
Publicado: (2021)

Wnt3a protects SH-SY5Y cells against 6-hydroxydopamine toxicity by restoration of mitochondria function
por: Wei, Lei, et al.
Publicado: (2015)

Nitroxide Radical-Containing Redox Nanoparticles Protect Neuroblastoma SH-SY5Y Cells against 6-Hydroxydopamine Toxicity
por: Pichla, Monika, et al.
Publicado: (2020)

Evaluation of 6-Hydroxydopamine and Rotenone In Vitro Neurotoxicity on Differentiated SH-SY5Y Cells Using Applied Computational Statistics
por: Simões, Rui F., et al.
Publicado: (2022)

Use of proton pump inhibitors and macrolide antibiotics and risk of acute kidney injury: a self-controlled case series study
por: Ikuta, Keiko, et al.
Publicado: (2022)

Effect of medication adherence on disease activity among Japanese patients with rheumatoid arthritis
por: Nakagawa, Shunsaku, et al.
Publicado: (2018)

Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms
por: Imai, Satoshi, et al.
Publicado: (2017)

Punicalagin Exerts Beneficial Functions in 6-Hydroxydopamine-Treated SH-SY5Y Cells by Attenuating Mitochondrial Dysfunction and Inflammatory Responses
por: Chu, Jianfeng, et al.
Publicado: (2018)

Carnosic Acid Alleviates Levodopa-Induced Dyskinesia and Cell Death in 6-Hydroxydopamine-lesioned Rats and in SH-SY5Y Cells
por: Lai, Chun-Yi, et al.
Publicado: (2021)

7,8,4′-Trihydroxyisoflavone, a Metabolized Product of Daidzein, Attenuates 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells
por: Ko, Yong-Hyun, et al.
Publicado: (2019)

Potential application of measuring serum infliximab levels in rheumatoid arthritis management: A retrospective study based on KURAMA cohort data
por: Nakae, Kazuto, et al.
Publicado: (2021)

Vitamin K2 Modulates Mitochondrial Dysfunction Induced by 6-Hydroxydopamine in SH-SY5Y Cells via Mitochondrial Quality-Control Loop
por: Tang, Hengfang, et al.
Publicado: (2022)

Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation
por: Katada, Yoshiki, et al.
Publicado: (2022)

Involvement of Mu Opioid Receptor Signaling in the Protective Effect of Opioid against 6-Hydroxydopamine-Induced SH-SY5Y Human Neuroblastoma Cells Apoptosis
por: Eftekhar-Vaghefi, Shahrzad, et al.
Publicado: (2015)

Pharmacognostical Analysis and Protective Effect of Standardized Extract and Rizonic Acid from Erythrina velutina against 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells
por: Silva, Aline H., et al.
Publicado: (2016)

Compressional-Puffing Pretreatment Enhances Neuroprotective Effects of Fucoidans from the Brown Seaweed Sargassum hemiphyllum on 6-Hydroxydopamine-Induced Apoptosis in SH-SY5Y Cells
por: Huang, Chun-Yung, et al.
Publicado: (2017)

Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson’s Disease via Activating the JAK2/STAT3 Pathway
por: Xu, ZhengHu, et al.
Publicado: (2021)

6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach
por: Magalingam, Kasthuri Bai, et al.
Publicado: (2022)

The Encapsulation of Citicoline within Solid Lipid Nanoparticles Enhances Its Capability to Counteract the 6-Hydroxydopamine-Induced Cytotoxicity in Human Neuroblastoma SH-SY5Y Cells
por: Margari, Andrea, et al.
Publicado: (2022)

STAT3 Polymorphism Associates With mTOR Inhibitor-Induced Interstitial Lung Disease in Patients With Renal Cell Carcinoma
por: Yamamoto, Kazuhiro, et al.
Publicado: (2022)

Baicalein Prevents 6-Hydroxydopamine-Induced Mitochondrial Dysfunction in SH-SY5Y Cells via Inhibition of Mitochondrial Oxidation and Up-Regulation of DJ-1 Protein Expression
por: Wang, Yue-Hua, et al.
Publicado: (2013)

Maackiain Ameliorates 6-Hydroxydopamine and SNCA Pathologies by Modulating the PINK1/Parkin Pathway in Models of Parkinson’s Disease in Caenorhabditis elegans and the SH-SY5Y Cell Line
por: Tsai, Rong-Tzong, et al.
Publicado: (2020)

Pharmacist-physician collaborative care for outpatients with left ventricular assist devices using a cloud-based home medical management information-sharing system: a case report
por: Katada, Yoshiki, et al.
Publicado: (2021)

Significance of pharmacist intervention to oral antithrombotic therapy in the pharmaceutical outpatient clinic of cardiovascular internal medicine: a retrospective cohort study
por: Kurimura, Tomoko, et al.
Publicado: (2023)

The Bacterial Toxin CNF1 Protects Human Neuroblastoma SH-SY5Y Cells against 6-Hydroxydopamine-Induced Cell Damage: The Hypothesis of CNF1-Promoted Autophagy as an Antioxidant Strategy
por: Travaglione, Sara, et al.
Publicado: (2020)

Syringin Prevents 6-Hydroxydopamine Neurotoxicity by Mediating the MiR-34a/SIRT1/Beclin-1 Pathway and Activating Autophagy in SH-SY5Y Cells and the Caenorhabditis elegans Model
por: Fu, Ru-Huei, et al.
Publicado: (2023)

Clusterin levels in undernourished SH-SY5Y cells
por: Rodríguez-Rivera, Carmen, et al.
Publicado: (2021)

Correction: Tang et al. Vitamin K2 Modulates Mitochondrial Dysfunction Induced by 6-Hydroxydopamine in SH-SY5Y Cells via Mitochondrial Quality-Control Loop. Nutrients 2022, 14, 1504
por: Tang, Hengfang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_89mtajf84ssjeesep9jcpt47ec